Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity Number: RFA-AR-14-016 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity Number: RFA-AR-14-015 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.84693.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a...
Source: Grants.gov - March 21, 2014 Category: Research Tags: Health Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2)
Funding Opportunity RFA-AR-14-015 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Leadership Center. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus: Network Research Sites (UH2/UH3)
Funding Opportunity RFA-AR-14-016 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis (RA) and Lupus Network Research Sites. The AMP RA and Lupus Network is designed to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs and peripheral blood cells. (Source: NIH F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 21, 2014 Category: Research Source Type: funding

State Public Health Approaches to Improving Arthritis Outcomes
Funding Opportunity Number: CDC-RFA-DP12-121003CONT14 Opportunity Category: ContinuationFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.945Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDCClosing Date: Mar 17, 2014Award Ceiling: Expected Number of Awards: 10Creation Date: Mar 12, 2014Funding Opportunity Description: State Public Health Approaches to Improving Arthritis Outcomes National Center for Chronic Disease Prevention and Health PromotionDivision o...
Source: Grants.gov - March 13, 2014 Category: Research Tags: Health Source Type: funding

Call for Applications: Lupus Foundation of America 2014 Career Development Award
Application Deadline: March 28, 2014 at 5 p.m. ET Purpose: To facilitate the professional development of heumatology, nephrology, and dermatology fellows, in the U.S. and Canada, interested in lupus research to wards a career as an independent clinician-scientist at an academic, medical, or research institution, with a research program having considerable focus on the investigation of basic, clinical, translational, behavioral, or epidemiological lupus research. Award Amount: $70,000 per year (for a maximum of 2 years) ELIGIBILITY To be eligible to apply, applicants must hold an M.D. (or equivalent...
Source: ScanGrants feed - February 25, 2014 Category: Research Authors: Lupus Foundation of America, Inc. Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Rheumatoid Arthritis/Lupus: Leadership Center (UM2)
Notice NOT-AR-14-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2014 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Rheumatoid Arthritis/Lupus Research Sites (UH2/UH3)
Notice NOT-AR-14-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2014 Category: Research Source Type: funding

Pilot and Feasibility Clinical Research Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)
Funding Opportunity Number: PAR-14-060 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.846Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS,...
Source: Grants.gov - January 11, 2014 Category: Research Tags: Health Source Type: funding

Chronic Illness Self-Management in Children and Adolescents (R21)
Funding Opportunity Number: PA-11-072 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthIncome Security and Social ServicesCFDA Number: 93.36193.83793.84693.865Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal g...
Source: Grants.gov - December 12, 2013 Category: Research Tags: Education Health Income Security and Social Services Source Type: funding

Chronic Illness Self-Management in Children and Adolescents (R01)
Funding Opportunity Number: PA-11-070 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationFood and NutritionHealthIncome Security and Social ServicesCFDA Number: 93.36193.83793.84693.84793.865Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Feder...
Source: Grants.gov - December 12, 2013 Category: Research Tags: Education Food and Nutrition Health Income Security and Social Services Source Type: funding

Call for Applications: 2014 Pierre Delmas Prize
Deadline for applications for the 2014 Pierre Delmas Prize is December 19, 2013. The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF), with the support of Servier, grant an important scientific award named after the late Pierre D. Delmas. As Professor of Medicine and Rheumatology at the University of Lyon, France, Director of the INSERM research unit 'Pathophysiology of Osteoporosis', Pierre Delmas was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases, partic...
Source: ScanGrants feed - December 10, 2013 Category: Research Authors: European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis/International Osteoporosis Foundation Source Type: funding

Arthritis and Aging Research Grant
In a collaborative effort, the Arthritis National Research Foundation (ANRF) and the American Federation for Aging Research (AFAR) are seeking grant applications that focus on studying the underlying mechanisms of the aging process as it relates to arthritis. Applicants:  Priority will be given to meritorious applications from younger, M.D. and/or Ph.D. applicants in early stage career development (equivalent to assistant professor and without serving as PI on an NIH R01 award). Budget and Project Period:  Applicants may request up to $100,000 in direct costs only.  The project period in respons...
Source: ScanGrants feed - November 26, 2013 Category: Research Authors: Arthritis National Research Foundation/American Federation for Aging Research Source Type: funding

Request for Information (RFI): Input on the Development of a Consortium for Signaling Networks to Critical Targets (CONNECT) in Rheumatoid Arthritis, Lupus and other Autoimmune Conditions
Notice NOT-AR-14-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 20, 2013 Category: Research Source Type: funding

Notice of Extension of the Expiration Date for NOT-AR-14-010 Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Long-Range Plan for Fiscal Year's (FY) 2015 - 2019
Notice NOT-AR-14-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2013 Category: Research Source Type: funding